Avid Bioservices to Participate at BIO International Convention 2018
-- Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity --
-- Company’s Newly Appointed Director of Business Development for
Details of Avid’s activities at BIO 2018 are as follows:
- Avid will host corporate booth #1073 showcasing the company’s comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services. Company representatives will provide a virtual tour of Avid’s 42,000 square foot state-of-the-art commercial biomanufacturing suite (Myford facility), which is in the unique position of being a validated facility with immediately available 2,000-liter scale bioreactor capacity. The company will also discuss the ongoing expansion of its process development capabilities and laboratories.
The Myford facility, located in
Tustin, California, incorporates a variety of cutting-edge, single-use equipment with the goal of ultimately accommodating a fully disposable biomanufacturing process. A wide range of innovative features are incorporated into the facility including monolithic modular clean rooms, dedicated support utilities for each key processing area, and the industry’s most advanced single-use production systems and flexible solutions. Uni-directional process flows separate personnel and materials and provide assurance that the design meets the most stringent regulatory requirements for commercial biologics drug substance manufacturing.
Additionally, Avid will dedicate a portion of its booth to celebrating the company’s 25 years of experience in biopharmaceutical development and manufacturing, which dates back to 1993. This anniversary coincides with the 25-year anniversary of the
Biotechnology Innovation Organization(BIO), which is also being celebrated this year.
- Joining the Avid team at BIO 2018 will be
Sandra C. Carbonneau, the company’s newly appointed director of business development for the East Coast. Mrs. Carbonneau has more than 26 years of relevant industry experience, including a 22-year tenure with Lonza, a global integrated solutions provider to the pharmaceutical and biotechnology industries. During her time with Lonza, she held positions of increasing responsibility spanning areas of manufacturing, quality assurance, compliance and contract management, culminating in her overseeing the company’s global commercial development for its mammalian business unit. Mrs. Carbonneau most recently served as director of business development in the New Englandregion at Integrated Project Services (IPS), a leading consulting firm for technically complex facilities worldwide. At Avid, she will play a key role in the company’s new customer acquisition efforts on the east coast of the US, while supporting all its existing clients in the eastern half of the country.
Roger Lias, Ph.D., Avid’s president and chief executive officer, will participate in a roundtable discussion titled, “Capacity Strategies – The Strategy Behind the Large Scale SUS vs. Stainless Steel Investment.” The roundtable discussion will take place from 1:00 – 2:00 p.m.Eastern on Wednesday, June 6th at booth #375 within the BioProcess Zone’s BPI Theatre. It will be part of the BPI Theatre’s “Emerging Techniques, Technologies and Strategies” track.
Sun Ra Bullins, director of manufacturing at Avid, will make a presentation titled, “The Perks and Pitfalls of a Single-Use Biopharmaceutical Facility.” The presentation will take place from 3:40 – 4:00 p.m.Eastern on Wednesday, June 6that booth #375 within the BioProcess Zone’s BPI Theatre. It will be part of the BPI Theatre’s “Emerging Techniques, Technologies and Strategies” track.
For more information on the
Kelly Pisarev Lord Avid Bioservices, Inc.(800) 987-8256 Stephanie Diaz(Investors) Vida Strategic Partners415-675-7401 email@example.com Tim Brons(Media) Vida Strategic Partners415-675-7402 firstname.lastname@example.org
Source: Avid Bioservices, Inc